Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | EXS73565 |
| Synonyms | |
| Therapy Description |
EXS73565 inhibits MALT1, potentially resulting in decreased tumor cell proliferation and inhibition of tumor growth (Ann Oncol (2023) 34 (suppl_2): S759). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| EXS73565 | EXS-73565|EXS 73565 | MALT1 Inhibitor 6 | EXS73565 inhibits MALT1, potentially resulting in decreased tumor cell proliferation and inhibition of tumor growth (Ann Oncol (2023) 34 (suppl_2): S759). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06980116 | Phase I | EXS73565 | Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies | Recruiting | GBR | ESP | 0 |